In a Dutch-Belgian trial, CT screening using nodule volume rather than diameter cut lung cancer deaths in men by about a quarter at 10 years, with a far lower false-positive rate than NLST.
NELSON randomised 15,789 current or former smokers (13,195 men and 2,594 women) aged 50-74 to CT screening at baseline, 1, 3 and 5.5 years or to no screening. Nodules were managed by volume and volume-doubling time, with an indeterminate category that triggered a repeat scan rather than a biopsy.
The primary analysis in men showed a lung cancer mortality rate ratio of 0.76 at 10 years. Screen-detected cancers were much more often stage I. The positive-screen rate was around 2%, far below NLST's, because the indeterminate category absorbed most small nodules.
NELSON confirmed NLST against a no-screening control and gave European programmes a workable protocol.
Lung screening works when it uses volumetric nodule management, and it works against a no-screening control. The protocol underpins the UK Targeted Lung Health Check programme and European recommendations. Benefit in women remains less precisely estimated.
The document that defines who is offered a scan in the United States, and therefore the document any argument about the screening eligibility gap has to engage with. Eligibility is still defined by pack-years and years since quitting rather than by an individual risk estimate.
A negative screening trial that saved a generation from a useless test, and the reason low-dose computed tomography had to be proved separately rather than assumed to work because it saw more.
Shares Lung screening eligibility by risk score, not pack-years, including high-risk never-smokers, Decide who is screened for lung cancer by individual risk, not by pack-years, Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement, NLST: yearly low-dose CT scans cut lung cancer deaths in heavy smokers.
Shares NLST & NELSON (low-dose CT screening), NLST: yearly low-dose CT scans cut lung cancer deaths in heavy smokers, AI in radiology, CT (computed tomography).
Shares NLST & NELSON (low-dose CT screening), Stage shift, Low-dose CT lung screening, AI in radiology.
Shares Stage shift, Low-dose CT lung screening, AI in radiology, Overdiagnosis and false alarms.
Shares Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial, Decide who is screened for lung cancer by individual risk, not by pack-years, Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement, Positive predictive value (PPV).
Shares Stage shift, AI in radiology, Overdiagnosis and false alarms, The hardest cancers are found late.
Shares Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement, Low-dose CT lung screening, Lung cancer roadmap: from Doll and Hill and the naming of tobacco, through the cytotoxic plateau, computed tomography screening, EGFR and ALK, immunotherapy by PD-L1, the perioperative trials and PACIFIC, to DLL3 in small-cell disease and a 2032 registry watch, The hardest cancers are found late.
Shares AI in radiology, Overdiagnosis and false alarms, CT (computed tomography), The hardest cancers are found late.